2-03-2023, 19:00

Pharvaris to Present in Upcoming March Investor

ZUG, Switzerland, March 02, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing
Globe Newswire2-03-2023, 19:00
24-02-2023, 18:55

Pharvaris to Highlight Positive Phase 2 Data from RAPIDe-1

ZUG, Switzerland, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing
Globe Newswire24-02-2023, 18:55